18-402C 18-402C . . . Directors Stock Appreciation Rights Plan which provides for automatic grants of 10,000 SARs to each Non-employee director on effective date of Plan and 1,000 additional SARs on each March 1st thereafter. Newly elected Non-employee Directors will be granted 10,000 SARs on date of their election
The North Carolina Directors Stock Appreciation Rights Plan is a program implemented by American Annuity Group, Inc. to reward its directors with stock appreciation rights (SARS) as part of their compensation package. This plan is specifically designed for directors serving in North Carolina, ensuring compliance with state regulations and offering attractive incentives to attract and retain top-level management. The North Carolina Directors Stock Appreciation Rights Plan of American Annuity Group, Inc. provides directors with the opportunity to benefit from the growth in the company's stock value over time. It allows participants to receive SARS, which are a type of equity-based compensation tool that enable directors to profit from the increase in the market price of American Annuity Group's stock. Directors who participate in this plan are granted SARS, which give them the right to receive a cash payment equal to the appreciation in the company's stock price. This payment is typically made upon the exercise of the SARS, which occurs when the predetermined vesting period has been completed or upon a triggering event such as a change of control or sale of the company. The directors have the flexibility to choose when to exercise their SARS and receive their cash payment. Under the North Carolina Directors Stock Appreciation Rights Plan, American Annuity Group, Inc. may offer different types of SARS based on the specific terms outlined in the plan document. These types may include Traditional SARS, Tandem SARS, Reload SARS, or Performance-Based SARS. Each type of SAR has unique features and conditions that determine when and how the directors can exercise their rights. Traditional SARS are the most commonly offered type, providing directors with a cash payout equal to the difference between the stock price on the date of exercise and the price on the date of grant. Tandem SARS, on the other hand, are granted in conjunction with stock options, allowing directors to choose whether to exercise their SARS or stock options based on market conditions. Reload SARS provide directors with the opportunity to receive additional SARS after exercising their initial SARS, enabling them to continue benefiting from future stock price increases. Performance-Based SARS, as the name suggests, are contingent upon the achievement of predetermined performance goals set by American Annuity Group, Inc. These goals could include financial targets, market share growth, or any other metric deemed important by the company. The North Carolina Directors Stock Appreciation Rights Plan of American Annuity Group, Inc. acts as a valuable compensation tool for the company's directors, aligning their interests with those of the shareholders. By linking compensation to the performance of the company's stock, this plan encourages directors to make decisions that drive the company's growth and long-term success.
The North Carolina Directors Stock Appreciation Rights Plan is a program implemented by American Annuity Group, Inc. to reward its directors with stock appreciation rights (SARS) as part of their compensation package. This plan is specifically designed for directors serving in North Carolina, ensuring compliance with state regulations and offering attractive incentives to attract and retain top-level management. The North Carolina Directors Stock Appreciation Rights Plan of American Annuity Group, Inc. provides directors with the opportunity to benefit from the growth in the company's stock value over time. It allows participants to receive SARS, which are a type of equity-based compensation tool that enable directors to profit from the increase in the market price of American Annuity Group's stock. Directors who participate in this plan are granted SARS, which give them the right to receive a cash payment equal to the appreciation in the company's stock price. This payment is typically made upon the exercise of the SARS, which occurs when the predetermined vesting period has been completed or upon a triggering event such as a change of control or sale of the company. The directors have the flexibility to choose when to exercise their SARS and receive their cash payment. Under the North Carolina Directors Stock Appreciation Rights Plan, American Annuity Group, Inc. may offer different types of SARS based on the specific terms outlined in the plan document. These types may include Traditional SARS, Tandem SARS, Reload SARS, or Performance-Based SARS. Each type of SAR has unique features and conditions that determine when and how the directors can exercise their rights. Traditional SARS are the most commonly offered type, providing directors with a cash payout equal to the difference between the stock price on the date of exercise and the price on the date of grant. Tandem SARS, on the other hand, are granted in conjunction with stock options, allowing directors to choose whether to exercise their SARS or stock options based on market conditions. Reload SARS provide directors with the opportunity to receive additional SARS after exercising their initial SARS, enabling them to continue benefiting from future stock price increases. Performance-Based SARS, as the name suggests, are contingent upon the achievement of predetermined performance goals set by American Annuity Group, Inc. These goals could include financial targets, market share growth, or any other metric deemed important by the company. The North Carolina Directors Stock Appreciation Rights Plan of American Annuity Group, Inc. acts as a valuable compensation tool for the company's directors, aligning their interests with those of the shareholders. By linking compensation to the performance of the company's stock, this plan encourages directors to make decisions that drive the company's growth and long-term success.